Related Experiment Video
Updated: Mar 16, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
miRNA-1283 Regulates the PERK/ATF4 Pathway in Vascular Injury by Targeting ATF4
Ling He1, Jing Yuan1, Qingyun Xu1
1Department of Chinese Medicine, Medical College of Jinan University, Guangzhou, 510632, Guangdong Province, PR China.
Background:
In our previous study, we found significant differences in the mRNA and microRNA (miRNA) levels among hypertensive patients with different degrees of vascular endothelial cells damage. These differences were closely associated with endoplasmic reticulum stress (ERS)-related proteins. Moreover, compared to the control group, the expression of transcription factor activating factor 4 (ATF4) was also found to be significantly different in the hypertensive patients with different degrees of vascular endothelial cells damage groups. These results were confirmed using gene prediction software, which showed synergistic effects between ATF4 and miR-1283. ATF4 is a key molecule in ERS. Three ERS pathways exist:protein kinase RNA-like ER kinase (PERK), activating transcription factor 6 (ATF6) and inositol-requiring enzyme-1 (IRE-1)-induced apoptosis. The PERK pathway is the most important and also includes the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) and ATF4. In this report, we studied the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2α-ATF4 signaling pathway using human umbilical vein endothelial cells (HUVECs) and mice.
Methodology/Principal Findings:
We verified the relationship between miR-1283 and ATF4 using a luciferase activity assay and observed the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2α-ATF4 signaling pathway in vivo and in vitro.
Conclusions/Significance:
ATF4 is a target gene of miR-1283, which regulates the PERK-eIF2α-ATF4 signaling pathway by inhibiting ATF4, and it plays a critical role in inducing injury in HUVECs and mouse heart tissue.
Insights
MicroRNA-1283 (miR-1283) inhibits activating transcription factor 4 (ATF4), regulating the PERK-eIF2α-ATF4 pathway. This mechanism is critical for endothelial cell injury in hypertension.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cell Biology
Background:
- Previous studies identified differential mRNA and microRNA (miRNA) levels in hypertensive patients, linked to endoplasmic reticulum stress (ERS) and activating transcription factor 4 (ATF4).
- Gene prediction suggested synergistic effects between ATF4 and miR-1283, highlighting ATF4's role in ERS pathways, particularly the PERK pathway.
- The PERK pathway involves eukaryotic translation initiation factor 2α (eIF2α) phosphorylation and ATF4 activation.
Purpose of the Study:
- To investigate the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2α-ATF4 signaling pathway.
- To elucidate the role of this pathway in human umbilical vein endothelial cells (HUVECs) and mouse models.
Main Methods:
- Luciferase activity assays were employed to verify the relationship between miR-1283 and ATF4.
- In vivo and in vitro experiments were conducted to observe the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2α-ATF4 signaling pathway.
Main Results:
- The study confirmed that ATF4 is a direct target gene of miR-1283.
- miR-1283 was shown to regulate the PERK-eIF2α-ATF4 signaling pathway by inhibiting ATF4 expression.
Conclusions:
- miR-1283 plays a critical role in inducing injury in HUVECs and mouse heart tissue by regulating the PERK-eIF2α-ATF4 pathway via ATF4 inhibition.
- These findings provide insights into the molecular mechanisms underlying endothelial cell damage in hypertension.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

